Last reviewed · How we verify
Behyd (benzylhydrochlorothiazide)
Behyd (generic name: benzylhydrochlorothiazide) is a drug. It is currently in unknown development for Congestive heart failure, Hypertensive disorder, Malignant hypertension.
Behyd works by blocking sodium reabsorption in the kidneys, which increases urine production and reduces blood pressure.
Behyd (benzylhydrochlorothiazide) is a small molecule modality used to treat congestive heart failure, hypertensive disorder, and malignant hypertension. Although its exact target and drug class are unknown, it is believed to work by inhibiting sodium reabsorption in the kidneys, leading to increased urine production and reduced blood pressure. Behyd is not currently listed as a patented or off-patent medication, and its commercial status is unclear. Further research is needed to fully understand its pharmacological properties and clinical applications. As a result, key safety considerations and dosing information are not well established.
At a glance
| Generic name | benzylhydrochlorothiazide |
|---|---|
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
Think of it like a sponge: when you squeeze a sponge, water comes out. Behyd helps the kidneys squeeze out excess water and salt from the blood, which reduces blood pressure and helps the heart work more efficiently.
Approved indications
- Congestive heart failure
- Hypertensive disorder
- Malignant hypertension
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Behyd CI brief — competitive landscape report
- Behyd updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Behyd
What is Behyd?
How does Behyd work?
What is Behyd used for?
What is the generic name of Behyd?
What development phase is Behyd in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Congestive heart failure
- Indication: Drugs for Hypertensive disorder
- Indication: Drugs for Malignant hypertension
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing